Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 28 November 2008:
Vol. 322. no. 5906, pp. 1395 - 1399
DOI: 10.1126/science.1164847
Prev | Table of Contents | Next

Reports

Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease

Atul R. Chopra,1* Jean-Francois Louet,1* Pradip Saha,1 Jie An,4 Franco DeMayo,1 Jianming Xu,1 Brian York,1 Saul Karpen,1,2 Milton Finegold,3 David Moore,1 Lawrence Chan,1 Christopher B. Newgard,4 Bert W. O'Malley1{dagger}

Hepatic glucose production is critical for basal brain function and survival when dietary glucose is unavailable. Glucose-6-phosphatase (G6Pase) is an essential, rate-limiting enzyme that serves as a terminal gatekeeper for hepatic glucose release into the plasma. Mutations in G6Pase result in Von Gierke's disease (glycogen storage disease–1a), a potentially fatal genetic disorder. We have identified the transcriptional coactivator SRC-2 as a regulator of fasting hepatic glucose release, a function that SRC-2 performs by controlling the expression of hepatic G6Pase. SRC-2 modulates G6Pase expression directly by acting as a coactivator with the orphan nuclear receptor ROR{alpha}. In addition, SRC-2 ablation, in both a whole-body and liver-specific manner, resulted in a Von Gierke's disease phenotype in mice. Our results position SRC-2 as a critical regulator of mammalian glucose production.

1 Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
2 Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
3 Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
4 Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC27710, USA.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: berto{at}bcm.tmc.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Molecular control of circadian metabolic rhythms.
S. Li and J. D. Lin (2009)
J Appl Physiol 107, 1959-1964
   Abstract »    Full Text »    PDF »
Glucose-6-phosphatase Catalytic Subunit Gene Family.
J. C. Hutton and R. M. O'Brien (2009)
J. Biol. Chem. 284, 29241-29245
   Abstract »    Full Text »    PDF »
Foxa2-dependent hepatic gene regulatory networks depend on physiological state.
I. M. Bochkis, J. Schug, N. E. Rubins, A. R. Chopra, B. W. O'Malley, and K. H. Kaestner (2009)
Physiol Genomics 38, 186-195
   Abstract »    Full Text »    PDF »
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas.
N. J. McKenna, A. J. Cooney, F. J. DeMayo, M. Downes, C. K. Glass, R. B. Lanz, M. A. Lazar, D. J. Mangelsdorf, D. D. Moore, J. Qin, et al. (2009)
Mol. Endocrinol. 23, 740-746
   Abstract »    Full Text »    PDF »
Von Gierke's Disease Adopts an Orphan (and Its Partner).
A. Cheng and A. R. Saltiel (2009)
Science Signaling 2, pe8
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)